Consonance Capital Management LP / CHRS
Consonance Capital Management LP’s Coherus Oncology Inc Position
Does Consonance Capital Management LP own Coherus Oncology Inc (CHRS)? Not currently — the last reported position was 2.02M shares worth $33M in Q1 2020; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$33M
Q1 2020
Shares
2.02M
% of Portfolio
+2.44%
Quarters Held
1
position exited
Position History CHRS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2020 | 2.02M | $33M | +2.44% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of CHRS.